Synapsoft logo
AI Insights from Disclosures
Searching...
Genomictree Inc. 228760
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
The early cancer detection in vitro diagnostics industry, to which Genomictree Inc. belongs, is a field that detects cancer at an early stage using biomarker-based molecular diagnostic technology. This industry deals with screening tests for the general asymptomatic population rather than traditional post-symptom diagnosis, and is a newly expanding market amid an increasing incidence of cancer due to an aging population.
Representative Director Ahn Seonghwan
Founded October 6, 2000
Corporation Type KOSDAQ
Industry Classification Research and experimental development on natural sciences and engineering
Corporate number 16011-0105498
Business number 314-81-36987
Phone Number 042-861-4551
Fax Number 042-861-4552
Company Address 44-6 Techno 10-ro, Yuseong-gu, Daejeon
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant